Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

0.4145 -0.0055 (-1.31%)
Streaming Delayed Price Updated: 12:35 PM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeoVax Labs, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
GeoVax to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022
Presentation to Focus on GEO-CM02 Being Developed as a 
Via NewMediaWire
News headline image
GeoVax to Participate in Maxim Group's 2022 Virtual Growth Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax Labs Retains CATO SMS To Manage Its Mid-Stage COVID-19 Vaccine Trials ↗
GeoVax Labs Inc (NASDAQ: GOVX) has engaged CATO SMS to manage its two ongoing Phase 2 trials of its COVID-19 vaccine candidate, GEO-CM04S1. One is testing the... 
Via Benzinga
News headline image
GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Geovax Labs: Q4 Earnings Insights ↗
Geovax Labs (NASDAQ:GOVX) reported its Q4 earnings results on Wednesday, March 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Geovax... 
Via Benzinga
News headline image
GeoVax Reports 2021 Year-End Financial Results and Provides Corporate Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Earnings Scheduled For March 9, 2022 ↗
Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (... 
Via Benzinga
News headline image
Earnings Preview For Geovax Labs ↗
Geovax Labs (NASDAQ:GOVX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-09. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
GeoVax Announces Key Staff Appointments
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Present at the 2022 BIO CEO & Investor Digital Conference
Atlanta, GA - (NewMediaWire) - February 08, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that... 
Via NewMediaWire
News headline image
GeoVax Announces Closing of $10 Million Private Placement
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers ATI Physical Therapy (NYSE:ATIP) stock increased by 22.7% to $3.73 during Friday's regular session. Trading volume for ATI Physical Therapy's stock is 14.3... 
Via Benzinga
GeoVax Announces $10 Million Private Placement
Atlanta, GA - (NewMediaWire) - January 14, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that it... 
Via NewMediaWire
News headline image
GeoVax Retains CATO SMS To Manage Gedeptin Phase 1/2 Clinical Trial ↗
GeoVax Labs, Inc. (NASDAQ: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced the engagement of CATO SMS to... 
Via Benzinga
News headline image
GeoVax Retains CATO SMS to Manage Gedeptin Phase 1/2 Clinical Trial
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax Appoints Dr. Kelly McKee as Chief Medical Officer
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax to Participate in Upcoming Life Sciences Investor Conferences
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax Issues Shareholder Update Letter
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
23 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... 
Via Benzinga
News headline image
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster ↗
GeoVax Labs Inc (NASDAQ: GOVX) initiated vaccine dosing in the Phase 2 portion of its Phase 1/2 trial of COH04S1 COVID-19 vaccine to target both the spike (S) and... 
Via Benzinga
News headline image
GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
GeoVax Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress
Nonhuman Primate Testing of Sudan and Marburg Vaccine Candidates Demonstrates Efficacious Immune Response 
Via NewMediaWire
Topics Intellectual Property Regulatory Compliance
News headline image
GeoVax Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property Regulatory Compliance
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
23 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a... 
Via Benzinga
News headline image
50 Biggest Movers From Yesterday ↗
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial... 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.